首页 › 基金 › Smith Group Asset Management, LLC › REGN
Smith Group Asset Management, LLC 对 REGN 的持仓历史
REGENERON PHARMACEUTICALS · 医疗保健
Smith Group Asset Management, LLC 在 Q3 2026 的 13F 申报中披露持有 REGN(REGENERON PHARMACEUTICALS)40,114 股,市值约 US$30.4M,约占其申报组合的 1.99%,在其申报持仓中市值排名第 24 位。 Smith Group Asset Management, LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-10-28 · 来源: SEC EDGAR Form 13F-HR
Smith Group Asset Management, LLC 对 REGN 的持仓演变
Smith Group Asset Management, LLC 于 Q3 2026 首次披露 REGN 持仓:40,114 股(约 US$30.4M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 40.11K | $30.42M | 新进 |
关于 REGN 与 13F 数据
REGN(REGENERON PHARMACEUTICALS)属于医疗保健行业。我们追踪的基金中还有 31 只申报持有 REGN,申报仓位最大的包括:Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 REGN 的基金
- Dodge & Cox 4.87M 股 · $3.04B · Q2 2026
- DODGE & COX 4.87M 股 · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M 股 · $1.16B · Q2 2026
更多关于 Smith Group Asset Management, LLC
常见问题
How long has Smith Group Asset Management, LLC held REGN?
Smith Group Asset Management, LLC has disclosed REGN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Smith Group Asset Management, LLC's current position in REGN?
As of Q3 2026, Smith Group Asset Management, LLC holds 40.11K shares of REGN (REGENERON PHARMACEUTICALS), valued at $30.42M, representing 1.99% of its reported portfolio and ranking #24.
Has Smith Group Asset Management, LLC been buying or selling REGN?
In the latest 13F filing (Q3 2026), Smith Group Asset Management, LLC newly opened its position in REGN.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.